Zhiyong Xiong - Publications

Clinical outcomes with first-line tislelizumab plus lenvatinib in unresectable hepatocellular carcinoma: a retrospective analysis.

Journal: PeerJ

Published: September 02, 2025

Dynamics changes of spleen volume predict survival outcomes in unresectable hepatocellular carcinoma treated with tislelizumab plus lenvatinib.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 20, 2025

PDLIM4 increases sphingolipid accumulation to promote cancer stem cell characteristics and chemotherapy resistance in colorectal cancer.

Journal: Communications biology

Published: August 06, 2025

Intervening in PIDD1 to Decrease Treg Cell Recruitment Boosts the Effectiveness of Radiofrequency Ablation Combined with anti-PD-1 Therapy in HCC.

Journal: Cellular and molecular gastroenterology and hepatology

Published: July 22, 2025

Intra-layer Na and inter-layer K doping synergistically enhance photocatalytic activity of g-C3N4.

Journal: Journal of colloid and interface science

Published: April 17, 2025

Cu doping induced asymmetric Cu-Vs-In active sites in In2S3 for efficient photocatalytic C2H4 conversion from CO2.

Journal: Journal of colloid and interface science

Published: January 06, 2025

Periplakin Attenuates Liver Fibrosis via Reprogramming CD44Low Cells into CD44High Liver Progenitor Cells.

Journal: Cellular and molecular gastroenterology and hepatology

Published: September 27, 2024

CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 01, 2024

Promoting the Corrosion Resistance of Mo-FeCoP@MnOx/NF via Double Protection Mechanisms Toward Electrolysis of Seawater at Ampere-Level Current Density.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: August 01, 2024

Role of cancer stem cell heterogeneity in intrahepatic cholangiocarcinoma.

Journal: Translational cancer research

Published: July 25, 2024

CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt/β-catenin pathway via the miR-452-5p/SOX15 axis.

Journal: Genomics

Published: April 22, 2024

Microvascularized tumor assembloids model for drug delivery evaluation in colorectal cancer-derived peritoneal metastasis.

Journal: Acta biomaterialia

Published: March 05, 2023